Treatment of kaposi sarcoma (KS) with liposomal doxorubicina single institution experience

被引：0
|
作者：
Karaca, Saziye B. [1 ]
机构：
[1] Ege Univ, Fac Med, Izmir, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] Pegylated liposomal doxorubicin (PLD) as first line treatment in AIDS-related Kaposi's sarcoma (AIDS-KS): A single institution retrospective study
    Dalu, D.
    Cona, M. S.
    De Francesco, D.
    Ammoni, L.
    Rota, S.
    Fasola, C.
    Foschi, A.
    La Verde, N. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S982 - S982
  • [2] Liposomal daunorubicin as treatment for Kaposi's sarcoma
    Petre, Christin E.
    Dittmer, Dirk P.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2007, 2 (03): : 277 - 288
  • [3] A 24 years' experience with Kaposi's sarcoma (KS) and renal transplantation (RT) in a single institution: Results with older and newer therapeutic strategies
    Messina, Maria
    Giraudi, Roberta
    Leonardi, Gianluca
    Mezza, Elisabetta
    Torta, Elisa
    Bertinetto, Patrizia
    Segoloni, Giuseppe Paolo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 537 - 537
  • [4] Palliative treatment of Kaposi sarcoma with radiotherapy: a single center experience
    Inan, Gonca Altinisik
    Aral, Ipek Pinar
    Arslan, Suheyla Aytac
    Tezcan, Yilmaz
    RADIATION ONCOLOGY JOURNAL, 2021, 39 (01): : 41 - 47
  • [5] Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi’s sarcoma (KS)
    M. Bendle
    J. Pealing
    P. Papanastasopoulos
    M. Bower
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 611 - 615
  • [6] Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS)
    Bendle, M.
    Pealing, J.
    Papanastasopoulos, P.
    Bower, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 611 - 615
  • [7] Liposomal drug targeting in the treatment of Kaposi's sarcoma
    Wernz, JC
    AIDS PATIENT CARE AND STDS, 1996, 10 (06) : 362 - 367
  • [8] Non-AIDS-related Kaposi's sarcoma: A single-institution experience
    Rescigno, Pasquale
    Di Trolio, Rossella
    Buonerba, Carlo
    De Fata, Gaia
    Federico, Piera
    Bosso, Davide
    Virtuoso, Antonella
    Izzo, Michela
    Policastro, Tania
    Vaccaro, Luca
    Cimmino, Gianfranco
    Perri, Francesco
    Matano, Elide
    Delfino, Mario
    De Placido, Sabino
    Palmieri, Giovannella
    Di Lorenzo, Giuseppe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2013, 4 (02): : 52 - 57
  • [9] KSHV (Kaposi sarcoma associated virus) viremia in Kaposi sarcoma (KS)
    Lebbé, C
    Pellet, C
    Kerob, D
    Dupuy, A
    Mourah, S
    Morel, P
    Rabian, C
    Calvo, F
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A83 - A83
  • [10] Treatment of Kaposi's Sarcoma (KS) with nab-paclitaxel
    Fortino, S.
    Santoro, M.
    Iuliano, E.
    Luci, M.
    Perricelli, A.
    Pomillo, A.
    ANNALS OF ONCOLOGY, 2016, 27
12345